MedPath

Trained Patient Involvement to Promote the Resumption of CPAP in Patients Who Have Discontinued Its Use

Not Applicable
Not yet recruiting
Conditions
Obstructive Sleep Apnea Syndrome
Interventions
Behavioral: peer-driven intervention
Registration Number
NCT04538274
Lead Sponsor
AGIR à Dom
Brief Summary

The primary objective of this randomized clinical trial is to evaluate the role of patient researchers in promoting the resumption of CPAP therapy in apneic patients who had previously stopped CPAP

Detailed Description

Obstructive Sleep Apnoea syndrome (OSA) is one of the most frequent chronic disease presenting with or without symptoms of excessive daytime sleepiness (EDS) and being accompanied by neurocognitive, cardiovascular and metabolic complications.

The first line therapy of obstructive sleep apnoea is continuous positive airway pressure (CPAP). CPAP is highly effective in symptomatic patients for reducing EDS and improving daily functioning, cognitive function, mood and quality of life. However, success of CPAP treatment is hampered by long term nonadherence in nearly half of patients. Non adherence to CPAP is less and less related to technical problems, but rather to users' profile, their representations of OSA and the benefits experienced from CPAP. Cognitive-behavioural and motivation enhancement therapies can promote adherence to CPAP treatment. In addition to health professionals, patients and public involvement (PPI) is more and more advocated in the field of education and research. Nevertheless, the level of evidence regarding efficacy of PPI and patient researchers remains to be demonstrated. The aim of this randomized clinical trial is to evaluate the role of patient researchers in promoting the resumption of CPAP therapy in apneic patients who had previously stopped CPAP

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
208
Inclusion Criteria
  • Over 18 years old
  • Diagnosed with of severe OSA (AHI ≥ 30 events/hour)
  • Discontinuation of CPAP 4 to 12 months after initiation Followed by the home health care provider Agiradom
  • Access to a computer and/or tablet and an internet connection
  • Oral and written French
  • Able to provide written informed consent
  • Affiliated to social security or beneficiary of such a scheme
Exclusion Criteria
  • CPAP cessation due to a resolution of the OSAS (e.g. weight loss after bariatric surgery) or another pathology that prevents the continuation of treatment (e.g. ENT surgery, etc.).
  • Severe and/or unstable comorbidity that required hospitalisation for decompensation in the previous year (heart, kidney, respiratory, liver, psychiatric or other insufficiency).
  • Patient being treated with a mandibular advancement orthosis
  • Lack of availability (e.g. night worker or patient who travels frequently, etc.).
  • Current participation in, participation in the month prior to inclusion in another clinical intervention research study that may impact the study: this impact is left to the investigator's discretion.
  • Referred to in Articles L1121-5 to L1121-8 of the CSP (corresponds to all protected persons: pregnant woman, breastfeeding mother, person deprived of liberty by judicial or administrative decision, person subject to a legal protection measure)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Patient researcher interventionpeer-driven interventionIntervention conducted by trained patient researchers to restart CPAP in addition to usual care
Primary Outcome Measures
NameTimeMethod
Evaluate the impact of a 6-month, peer-driven intervention to promote the resumption of CPAP after discontinuation6 months after inclusion

The range of patients reusing CPAP in the intervention group The difference in percentages of patients who reuse CPAP between the peer-driven intervention group and the control group.

Secondary Outcome Measures
NameTimeMethod
Ageinclusion

This variable will be used to assess predictors of positive response to patient researcher intervention

Feasibility and the execution of the peer-driven interventionAt 6 month after inclusion

Evaluate the feasibility and the execution of the peer-driven intervention

marital status with infants (<10 years) or notinclusion

This variable will be used to assess predictors of positive response to patient researcher intervention

Education levelinclusion

This variable will be used to assess predictors of positive response to patient researcher intervention

Comorbiditiesinclusion

Charlson index will be used to assess predictors of positive response to patient researcher intervention

Genderinclusion

This variable will be used to assess predictors of positive response to patient researcher intervention

employment and socio-professional statusinclusion

This variable will be used to assess predictors of positive response to patient researcher intervention

alcohol-smoking statusinclusion

This variable will be used to assess predictors of positive response to patient researcher intervention

Evaluate the impact of the peer-driven intervention on adherence to CPAP compared to the control group6 month after inclusion

the difference in percentages of patients who reuse to CPAP with at least 4 hours' use /night for 70% of nights

Patient Self-Efficacy Measure for Sleep ApneaAt inclusion and after 6 months

The Self-Efficacy Measure for Sleep Apnea (SEMSA) questionnaire, a tool with strong psychometric properties and with the potential for identifying patient perceptions will be completed at inclusion (M0) and at the 6-month follow-up (M6). This variable will be used to assess predictors of positive response to patient researcher intervention

Patient knowledge, skill, and confidence for self-managementAt inclusion and after 6 months

The Patient Activation Measure (PAM) qestionnaire, a measure that assesses patient knowledge, skill, and confidence for self-management, will be completed at inclusion (M0) and at the 6-month follow-up (M6) This variable will be used to assess predictors of positive response to patient researcher intervention

Patient satisfaction and peer satisfactionAt 6 month after inclusion

Patient satisfaction with the peer-driven intervention at 6 months will be measured on a 4-point Likert scale : very dissatisfied, dissatisfied, satisfied, very satisfied.

Satisfaction of PI representatives will be measured on a 4-point Likert scale: very dissatisfied, dissatisfied, satisfied, very satisfied.

CPAP treatmentinclusion

Date of initiation of CPAP and date and cause of CPAP discontinuation

Disease-specific quality of lifeAt inclusion and after 6 months

The Functional Outcomes of Sleep Questionnaire (FOSQ10) will be completed at inclusion (M0) and at the 6-month follow-up (M6).

This variable will be used to assess predictors of positive response to patient researcher intervention

BMI Body Mass Indexinclusion

This variable will be used to assess predictors of positive response to patient researcher intervention

fragility and social precariousnessinclusion

EPICES score will be used to assess predictors of positive response to patient researcher intervention

medication adherenceinclusion

Girerd Score. This variable will be used to assess predictors of positive response to patient researcher intervention

OSA historyinclusion

date of diagnosis of OSA

Excessive daytime sleepiness (EDS score)inclusion

Epworth Sleepiness Scale will be used to assess predictors of positive response to patient researcher intervention

Baseline Apnea-Hypopnea Index (AHI)inclusion

This variable will be used to assess predictors of positive response to patient researcher intervention

© Copyright 2025. All Rights Reserved by MedPath